Ralph A. DeFronzo, MD, discusses the utilization of glucagon-like peptide-1 agonists and incorporating evidence-based guidelines into practice when considering the use of incretin-based therapies for type 2...
In this video, Dr Christie Ballantyne from Baylor College of Medicine talks about the challenges in preventive cardiology, including medication adherence.
Jeff Hutchins, PhD, discusses a novel mechanism that stimulates the immune system by providing the antigens it requires to recognize, target, and specifically destroy cancer cells in a “natural” way.
